Expending Role of Microsatellite Instability in Diagnosis and Treatment of Colorectal Cancers
Authors:
Open Access
- 11 July 2017
- journal article
- review article
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 48 (4) , 305-313
Abstract
Background: Colorectal carcinomas with high-frequency microsatellite instability (MSI-H) account for 15% of all colorectal cancers, including 12% of sporadic cases and 3% of cancers associated with Lynch syndrome (also known as hereditary nonpolyposis colorectal cancer syndrome, HNPCC). Lynch syndrome is an autosomal dominant hereditary cancer syndrome, caused by germline mutations in mismatch repair genes, including MLH1, MSH2, MSH6 and PMS2. Methods: Published articles from peer-reviewed journals were obtained from PubMed, Google Scholar and Clinicaltrials.gov. Based on the recent research data, we provide an update on the MSI testing, along with the evolving role of MSI in diagnosis, prognosis and treatment of colorectal cancers. Results: Studies have led to significant advances in the molecular pathogenesis and clinicopathological characteristics of MSI-H colorectal cancers. Emerging evidence suggests that colorectal cancers with MSI-H show different outcome and treatment response from those with microsatellite stable (MSS) tumors. Therefore, MSI testing is essential not only in the genetic context, but it may also have important prognostic and predictive value of response to chemotherapy and immunotherapy. Conclusions: Many experts and professional authorities have recommended a universal MSI testing in all individuals newly diagnosed with colorectal cancers.Keywords
Funding Information
- King's College London
This publication has 67 references indexed in Scilit:
- Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian seriesAnnals of Oncology, 2012
- Extracolonic Manifestations of Lynch SyndromeClinics in Colon and Rectal Surgery, 2012
- Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch SyndromeJAMA, 2011
- DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant TherapyJNCI: Journal of the National Cancer Institute, 2011
- Molecular Genetics of Colorectal CancerAnnual Review of Pathology: Mechanisms of Disease, 2011
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon CancerJournal of Clinical Oncology, 2010
- Microsatellite instability in colorectal cancer—the stable evidenceNature Reviews Clinical Oncology, 2010
- Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapyCancer Chemotherapy and Pharmacology, 2009
- Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatinAnnals of Oncology, 2009
- EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndromeGenetics in Medicine, 2009